Hypertension meetings & conferences

2nd International Conference on Prehypertension and CardioMetabolic Syndrome

January 31 – February 3, 2013 Barcelona, Spain

It is our pleasure to invite you to participate in The 2nd International Conference on Prehypertension and CardioMetabolic Syndrome, which will take place in Barcelona, Spain from January 31 - February 3, 2013.

Prehypertension is associated with other components of the metabolic syndrome i.e. obesity, glucose intolerance and dyslipidemia. The association is due to common mechanistic pathways and has implications on cardiovascular complications. Diet and exercise but not drug therapy benefit all components of the metabolic syndrome. Antihypertensive medications may lead to deterioration in glucose tolerance while glucose lowering agents may affect blood pressure. Thus, any discussion about the approach to prehypertension must be done in context to the whole cardio metabolic risk.

The Conference will discuss Important Topics such as:

Prehypertension - Definition, Classification, Diagnosis and Epidemiology

Progression of Hypertension, Increased Cardiovascular Risk, Vascular and End Organ Damage in Prehypertension

Screening and Early Diagnosis of Prehypertension and Subclinical Cardiovascular Damage

PreHT 2013 Secretariat: Paragon Conventions
Email: secretariat@prehypertension.org Website: www.prehypertension.org

7th International DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome, and Pregnancy

March 14-16, 2013 Florence, Italy

DIP 2013, the 7th International DIP Symposium on Diabetes, Hypertension, Metabolic Syndrome, and Pregnancy, will bring together clinicians, researchers, nurses, and healthcare workers involved in the treatment of diabetes and pregnancy, as well as other conditions that characterise a high-risk pregnancy.

Attendees will receive the most up-to-date scientific information, new perspectives, and a top scientific programme featuring world renowned experts. Florence, the beautiful city of art and science, is the perfect setting for knowledge sharing and networking at this highly specialised international event.

Kenes International
1-3 Rue de Chantepoulet
PO Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
Email: dip@kenes.com

Pulmonary Hypertension Association's 10th International PH Conference and Scientific Sessions

The Power of One: From a Kitchen Table to Around the World

June 22-24, 2012 Orlando, Florida

In 1990, four women gathered around a kitchen table in Florida and started an organization that would become the Pulmonary Hypertension Association (PHA). PHA has served as the center point of the PH community's progress toward new research and treatments, increased awareness, education and support for the people who live and work with this disease on a daily basis. In celebration of PHA's 10th International PH Conference and Scientific Sessions, we'll be returning to the state where our journey began over 20 years ago.

Celebrating this special 10th International PH Conference in Florida provides the PH community with the perfect opportunity to look back at the progress that has been made since our groundwork was first laid around that kitchen table for research, advocacy and education. While our PHamily - including patients, caregivers, researchers, physicians, nurses and everyone else who lives with, works with or knows about PH - has expanded greatly since 1990, we will always consider Florida as the heart and home of our organization thanks to what our four founders accomplished there.

Join us on this homecoming journey as we celebrate the history of our organization and bring together the PH community. We look forward to seeing you in Florida in 2012!

 55th Annual Thomas L. Petty Aspen Lung Conference

“Mechanics and Mechanisms of Pulmonary Hypertension”

June 6-9, 2012 Aspen, Colorado

The theme of the 55th Meeting of the Thomas L. Petty Aspen Lung Conference is “Mechanics and Mechanisms of Pulmonary Hypertension”. Emphasizing the integration of basic, translational and clinical sciences, the meeting will focus on the utilization of new strategies and technologies to investigate the pathogenesis, treatments and outcomes of pulmonary hypertension. Anchored by twelve “state-of-the-art” presentations delivered by international experts with accompanying abstract presentations, the thematic sessions will address epidemiology, progenitor cell biology, the role of inflammation, genetic somatic mutations and epigenetics, the impact of right ventricle (RV) dysfunction and RV-pulmonary artery coupling, the etiology and implication of PAH in WHO class III disease and prospects for novel disease modifying and preventive therapies. The Conference Summary will be presented by Werner Seeger, M.D., Professor of Medicine, Chief of the Department of Internal Medicine at the University Giessen Hospital, Germany. Dr. Seeger is Chairman of the Lung Center, and the Director of the Max Planck Institute for Heart and Lung Research and one of the world’s preeminent experts in the field of pulmonary vascular disease.

For more information, contact:

Todd Bull, M.D., c/o Jeanne Cleary
Thomas L. Petty Aspen Lung Conference
Anschutz Medical Campus, Research 2, Box C272, 9th Floor
12700 East 19th Avenue, Aurora, CO 80045
Phone: (303) 358-2797. Fax: (720) 851-1034. E-Mail:
Jeanne.Cleary@ucdenver.edu

or visit our website at
www.aspenlungconference.org
 

3rd International Congress on Abdominal Obesity

July 9-12, 2012 Québec City, Québec, Canada

The 3rd International Congress on Abdominal Obesity (ICAO 2012) is a highly anticipated event that will build on the success of last year’s Congress, held in Buenos Aires, Argentina. The Congress’s primary objective is to bring together medical professionals from all specialties to exchange ideas and information and raise awareness of abdominal obesity as a new modifiable risk factor which, along with traditional risk factors, plays a central role in this new concept of global cardiometabolic risk.

This relatively new Congress’s innovative multidisciplinary approach has facilitated the development of a new medical paradigm, whereby complications as hypertension, dyslipidemia, type 2 diabetes, and cardiovascular disease are no longer evaluated and treated in isolation.

We look forward to seeing you in Québec City, Québec, Canada, for what promises to be an exciting and cutting edge gathering of medical professionals of varied interests and backgrounds.

Abstract Topics

Abdominal Obesity/Body Fat Distribution
Acute Coronary Syndromes
Adipokines
Adipose Tissue
Cardiometabolic Risk
Cardiovascular Disease
Childhood Obesity
Clinical Cardiology
Clinical Trials
Diabetes
Ectopic Fat
Epidemiology
Ethnicity
Gender Differences
Genetics
Hypertension
Inflammation
Insulin Resistance
Interventional Cardiology
Lipids/Lipoproteins
Metabolic Syndrome
Nutrition
Obesity
Pathophysiology/Basic Science/Animal Studies
Pathophysiology/Clinical Science/Human Studies
Physical Activity/Exercise
Prevention
Smoking
Steroid Hormones
Thrombosis

Contact Us

Kenes International
1-3 Rue de Chantepoulet
PO Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
Email: icao@kenes.com

Pan American Heart Failure Congress (PAHF 2012)

October 18-21, 2012 Panama City, Panama

Cardiovascular disorders are the main cause of morbidity and mortality in many countries around the world including Latin American countries. The Pan American Congress on Heart failure will provide an in-depth focus on the best approaches for preventing and treating heart failure (HF) of various etiologies. Topics range from early recognition and intervention in high risk patients to the expanding use of drugs and devices to monitor and treat heart failure and detect evidence of worsening. The curriculum includes updates on treatment of systemic and pulmonary hypertension management of patients with HF due to coronary disease, acute decompensate HF, systolic and diastolic HF, cardiomyopathies and valvular heart disease. Atrial fibrillation, use of biomarkers and devices to aid in diagnosis, expanding indications for implantable defibrillators and cardiac resynchronization therapy, as well as treatment of sleep apnea and stem cell therapy.

Secretariat: Paragon Conventions
Tel: +41 22 5330 948, Fax: +41 22 5802 953
Email: secretariat@pahfcongress.com